Publications
May 1, 2011
- Diabetes
How does type 1 diabetes develop?: The notion of homicide or β-cell suicide revisited
Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Peitropaolo M, Arvan PR, von Herrath M, Markel DS, Rhodes CJ
May 1, 2011
- Cellular & Molecular Immunology
Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?
Christen U, von Herrath MG
May 1, 2011
- European Journal of Immunology
TLR2 signaling improves immunoregulation to prevent type 1 diabetes
Filippi CM, Ehrhardt K, Estes EA, Larsson P, Oldham JE, von Herrath MG
Apr 1, 2011
- Journal of Experimental Medicine
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay
Diana J, Brezar V, Beaudoin L, Dalod M,Mellor A, Tafuri A, von Herrath M, Boitard C, Mallone R, Lehuen A
Mar 1, 2011
- Clinical and Experimental Immunology
Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model
Bresson D, von Herrath MG
Feb 1, 2011
- Science Translational Medicine
Humanizing animal models: a key to autoimmune diabetes treatement
Bresson D, von Herrath M
Jan 1, 2011
- Human Vaccines
Type 1 diabetes vaccine development: animal models vs. humans
Boettler T, von Herrath M
Jan 1, 2011
- Expert Review of Clinical Immunology
Protection against or triggering of Type 1 diabetes? Different roles for viral infections
Boettler T, von Herrath M
Jan 1, 2011
- Seminars in Immunopathology
Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology
Coppieters KT, Roep BO, von Herrath MG
Jan 1, 2011
- PLoS One
Increased memory conversion of naïve CD8 T cells activated during late phases of acute virus infection due to decreased cumulative antigen exposure
Fousteri G, Dave A, Juedes A, Juntti T, Morin B, Togher L, Farber DL, von Herrath M
Jan 1, 2011
- Physiological Reviews
Type 1 diabetes: etiology, immunology, and therapeutic strategies
Van Belle TL, Coppieters KT, von Herrath MGVan Belle TL, Coppieters KT, von Herrath MG
Dec 1, 2010
- Int Immunopharmacol
Boettler T, von Herrath MG
